Literature DB >> 25813470

Phosphohistone H3: implications for clinical practice and risk assessment in meningioma.

Adriana Olar1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 25813470      PMCID： PMC4482867          DOI： 10.1093/neuonc/nov047

Source DB:  PubMed          Journal:  Neuro Oncol        ISSN： 1522-8517            Impact factor:   12.300


× No keyword cloud information.
  16 in total

1.  Prognostic significance of the mitotic index using the mitosis marker anti-phosphohistone H3 in meningiomas.

Authors:  Yoo-Jin Kim; Ralf Ketter; Wolf-Ingo Steudel; Wolfgang Feiden
Journal:  Am J Clin Pathol       Date:  2007-07       Impact factor: 2.493

2.  Reproducibility of mitosis counting in 2,469 breast cancer specimens: results from the Multicenter Morphometric Mammary Carcinoma Project.

Authors:  P J van Diest; J P Baak; P Matze-Cok; E C Wisse-Brekelmans; C M van Galen; P H Kurver; S M Bellot; J Fijnheer; L H van Gorp; W S Kwee
Journal:  Hum Pathol       Date:  1992-06       Impact factor: 3.466

3.  Chromatin condensation is not associated with apoptosis.

Authors:  M J Hendzel; W K Nishioka; Y Raymond; C D Allis; D P Bazett-Jones; J P Th'ng
Journal:  J Biol Chem       Date:  1998-09-18       Impact factor: 5.157

4.  Histone phosphorylation and chromatin structure during mitosis in Chinese hamster cells.

Authors:  L R Gurley; J A D'Anna; S S Barham; L L Deaven; R A Tobey
Journal:  Eur J Biochem       Date:  1978-03

5.  Mitosis-specific phosphorylation of histone H3 initiates primarily within pericentromeric heterochromatin during G2 and spreads in an ordered fashion coincident with mitotic chromosome condensation.

Authors:  M J Hendzel; Y Wei; M A Mancini; A Van Hooser; T Ranalli; B R Brinkley; D P Bazett-Jones; C D Allis
Journal:  Chromosoma       Date:  1997-11       Impact factor: 4.316

6.  Mitotic Index is an Independent Predictor of Recurrence-Free Survival in Meningioma.

Authors:  Adriana Olar; Khalida M Wani; Erik P Sulman; Alireza Mansouri; Gelareh Zadeh; Charmaine D Wilson; Franco DeMonte; Gregory N Fuller; Kenneth D Aldape
Journal:  Brain Pathol       Date:  2014-10-29       Impact factor: 6.508

7.  Frequent mitotic activity in banal melanocytic nevi uncovered by immunohistochemical analysis.

Authors:  Katharina Glatz; Christoph Hartmann; Milos Antic; Heinz Kutzner
Journal:  Am J Dermatopathol       Date:  2010-10       Impact factor: 1.533

8.  Sensitivity and usefulness of anti-phosphohistone-H3 antibody immunostaining for counting mitotic figures in meningioma cases.

Authors:  Shintaro Fukushima; Mizuhiko Terasaki; Kiyohiko Sakata; Naohisa Miyagi; Seiya Kato; Yasuo Sugita; Minoru Shigemori
Journal:  Brain Tumor Pathol       Date:  2009-10-27       Impact factor: 3.298

9.  Mitosis-specific marker phospho-histone H3 in the assessment of mitotic index in uterine smooth muscle tumors: a pilot study.

Authors:  Emanuela Veras; Anais Malpica; Michael T Deavers; Elvio G Silva
Journal:  Int J Gynecol Pathol       Date:  2009-07       Impact factor: 2.762

10.  Level of phosphohistone H3 among various types of human cancers.

Authors:  Amy Sun; Wei Zhou; Jared Lunceford; Peter Strack; Lisa M Dauffenbach; Christopher A Kerfoot
Journal:  BMJ Open       Date:  2012-10-12       Impact factor: 2.692
View more
  1 in total

1.  The Utility of Phosphohistone H3 in Inter-Observer Variability of Mitotic Count in Meningioma, is There Any Benefit?

Authors:  Hana Saffar; Hoda Okhovat; Saeed Arbabsoleymani; Seyed Mohammad Tavangar; Alireza Khoshnevisan; Ghazal Hajinasrollah; Zahra Hamidi Afra; Hiva Saffar
Journal:  Asian Pac J Cancer Prev       Date:  2021-07-01
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.